Follow The Filings

CDXS Codexis

Codexis earnings company data as of 4:46 AM ET 11/1

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CDXS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CDXS insider trades
  • None no insider bought on the open market
  • $4.9M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Opaleye Management Inc. 10% owner
    Sale
    $878K 514,341 shares at $1.71 74% of stake
    Traded Nov 26, 2025–Dec 1, 2025 Filed Dec 15, 2025
  2. Opaleye Management Inc. 10% owner
    Sale
    $1.9M 1,063,211 shares at $1.76 83% of stake
    Traded Nov 7–11 Filed Dec 15, 2025
  3. Dennis P Wolf Director
    Sale
    $14K 8,952 shares at $1.56 6.1% of stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
  4. Opaleye Management Inc. 10% owner
    Sale
    $2.1M 1,082,459 shares at $1.94 9.4% of stake
    Traded Nov 12, 2025 Filed Nov 14, 2025

Also filed in the last 12 months, not counted as buying or selling: 9 sales to cover taxes and 2 stock grants.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
8-K 8.01,9.01
424B5
8-K 2.02,8.01
424B5
SCHEDULE 13G/A —
8-K 5.07
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
DEF 14A
DEFA14A
SCHEDULE 13G —
8-K 5.02
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,9.01
10-K
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf